Lyra Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lyra Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Lyra Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $20.7M, a 241% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $20.7M +$14.6M +241% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $21.5M +$20.1M +1413% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $45.6M +$43.8M +2400% Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $33.2M +$31M +1395% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $6.07M +$5.47M +899% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.42M +$560K +65.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.83M +$716K +64.6% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $2.22M +$868K +64.1% Dec 31, 2022 10-K 2024-03-22
Q3 2022 $608K -$988K -61.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $860K -$974K -53.1% Jun 30, 2022 10-Q/A 2022-11-02
Q1 2022 $1.11M -$960K -46.4% Mar 31, 2022 10-Q/A 2022-11-02
Q4 2021 $1.36M -$946K -41.1% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $1.6M -$933K -36.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.83M -$921K -33.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $2.07M -$894K -30.2% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $2.3M -$881K -27.7% Dec 31, 2020 10-K 2022-03-09
Q3 2020 $2.53M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $2.76M Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $2.96M Mar 31, 2020 10-Q 2020-05-28
Q4 2019 $3.18M Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.